Kellerhals Carrard advised the shareholders of Gene Predictis. NIMGenetics Genomica y Medicina, S.L. completed the acquisition of Gene Predictis, S.A, a Swiss-based medical diagnostic company, and leader...
Kellerhals Carrard advised the shareholders of Gene Predictis. NIMGenetics Genomica y Medicina, S.L. completed the acquisition of Gene Predictis, S.A, a Swiss-based medical diagnostic company, and leader...
You must be a Standard 1 Year member to access this content.